| Abstract: | Bone tissue engineering offers the prospect of alternative therapies for clinically relevant skeletal defects. Poly(butylene succinate) (PBSu) is a biodegradable and biocompatible polyester which possesses some unfavorable biomaterial properties. In order to improve this limitation, we developed PBSu/hydroxyapatite (HA) and PBSu/β-tricalcium phosphate (TCP) composites to support the growth and osteogenic differentiation of human mesenchymal stem cells (hMSCs). The results showed that phase separation morphology of the composites were detected in both PBSu/HA and PBSu/TCP films where calcium phosphate (HA and TCP) dispersed thoroughly into PBSu. The addition of either HA or TCP increased the hydrophilicity of the resulting composites. All the materials appeared to be biocompatible and supported in vitro growth and osteoblast differentiation of hMSCs. In conclusion, the currently developed composite materials possess good biocompatibility and allow the growth and osteogenic differentiation of hMSCs in vitro, suggesting their potential application in stem cell-based bone engineering. |
